Robert L. Strausberg

J. Craig Venter Institute — United States

Medicine · Health Sciences

61h-index29.4kcitations280works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic factors in colorectal cancer(60), Cancer Genomics and Diagnostics(54), Colorectal Cancer Treatments and Studies(36), Immunotherapy and Immune Responses(26), Genomics and Phylogenetic Studies(25)

Publications278 total

Supplemental figure S1A, S1B, S2A, S2B, S3 from Altered Expression and Splicing of <i>ESRP1</i> in Malignant Melanoma Correlates with Epithelial–Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity
2023Open Access
Data from Altered Expression and Splicing of <i>ESRP1</i> in Malignant Melanoma Correlates with Epithelial–Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity
2023Open Access
Supplemental figure legends from Altered Expression and Splicing of <i>ESRP1</i> in Malignant Melanoma Correlates with Epithelial–Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity
2023Open Access
Supplementary Figures 1 - 5 from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches
2023Open Access
Supplementary Methods from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches
2023Open Access
Supplementary Figure 2 from Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
2023Open Access
Supplementary Table 3 from Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
2023Open Access
Data from Altered Expression and Splicing of <i>ESRP1</i> in Malignant Melanoma Correlates with Epithelial–Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity
2023Open Access
Supplementary Table 1 from Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
2023Open Access
Supplementary Table 4 from Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
2023Open Access
Supplementary Figures 1 - 5 from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches
2023Open Access
Supplementary Figure Legend from Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
2023Open Access
Supplemental table 1 from Altered Expression and Splicing of <i>ESRP1</i> in Malignant Melanoma Correlates with Epithelial–Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity
2023Open Access
Supplementary Table 7 from Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
2023Open Access
Supplementary Table 6 from Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
2023Open Access
Data from NY-ESO-1 Expression in Meningioma Suggests a Rationale for New Immunotherapeutic Approaches
2023Open Access
Supplementary Figure 2 from Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
2023Open Access
Supplementary Table 2 from Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
2023Open Access
Data from Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
2023Open Access
Supplementary Table 2 from Tumor Subtype-Specific Cancer–Testis Antigens as Potential Biomarkers and Immunotherapeutic Targets for Cancers
2023Open Access
page 1 of 14Next →

Frequent Co-authors

J. Craig Venter(12), Dana Busam(10), Gregory J. Riggins(10), Andrew J.G. Simpson(8), Aaron L. Halpern(7), Brian J. Stevenson(7), Ewen F. Kirkness(6), Christian Iseli(6), Karin Remington(5), Yu-Hui Rogers(5), Brian P. Walenz(5), Justin Johnson(5), Qi Zhao(5), C. Victor Jongeneel(5), Granger Sutton(4), Karen Beeson(4), M.E. Frazier(4), Samuel Lévy(4), Michael Christie(4), Jayesh Desai(4)